Our therapy areas
Unlocking the power of what science can do
The path to new treatments
The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Oncology; BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology); and Rare Disease.
Cardiovascular, Renal and Metabolism
CVRM (Cardiovascular, Renal and Metabolism) is one of our main therapy areas because science continues to uncover commonalities between metabolism, heart failure, arterial vascular disease and renal disease – four distinct but interrelated areas.
Respiratory & Immunology
We are entering an era of unprecedented potential to deliver scientific breakthroughs within asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and chronic cough.
Our mission is to transform the lives of people affected by rare diseases and devastating conditions. By understanding patients’ unique needs, we can research and develop innovative medicines, support access and advocate for the rare disease community.
Other disease areas
We have medicines and vaccines in other disease areas that have an important impact for patients. As such, we are selectively active in the areas of autoimmunity, infection & vaccines, neuroscience and gastroenterology, where we follow an opportunity-driven approach and often work through partnerships.
An exciting pipeline
Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.
projects in our pipeline
new molecular entities in our late-stage pipeline
new molecular entities under review
Veeva ID: Z4-43253
Date of preparation: March 2022